Marizyme receives clearance from FDA for DuraGraft device
The company will focus on implementing its plans to commercialise the device in the US.
09 October 2023
09 October 2023
The company will focus on implementing its plans to commercialise the device in the US.
A UK National Institute for Health and Care Research (NIHR) study has found smartphone-based treatment for diabetes could be greatly beneficial for expecting mothers living with the condition.
Masimo awarded the EU MDR CE mark for LiDCO BIC module built to connect to multi-patient monitoring platforms providing greater oxygen delivery insights.
The SiPore21 acts like a sieve, physically preventing enzymes from interacting with food and reducing its breakdown into its basic units.
The company plans to incorporate the Caption Guidance technology into other ultrasound systems, such as handheld systems.
Limmatech, a GSK spinoff focused on combatting antimicrobial resistance, had sought series A funding seven years after foundation.
The company aims to be ready to seek IDE approval for the pivotal trial by the end of next year.
Discover how biosensor technologies are benefiting the healthcare and diagnostics field in an exclusive interview with Marius Dagys, Head of the Department Institute of Biochemistry at the Life Sciences Center of Vilnius University.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
Give your business an edge with our leading industry insights.